Royal Bank of Canada’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-18,255
| Closed | -$3.02M | – | 8191 |
|
|
2021
Q2 | $3.02M | Sell |
18,255
-36,160
| -66% | -$6.04M | ﹤0.01% | 2706 |
|
|
2021
Q1 | $8.34M | Buy |
54,415
+45,672
| +522% | +$6.2M | ﹤0.01% | 1882 |
|
|
2020
Q4 | $1.1M | Buy |
8,743
+6,198
| +244% | +$693K | ﹤0.01% | 3413 |
|
|
2020
Q3 | $259K | Sell |
2,545
-499
| -16% | -$50.9K | ﹤0.01% | 4353 |
|
|
2020
Q2 | $297K | Buy |
3,044
+1,847
| +154% | +$172K | ﹤0.01% | 4168 |
|
|
2020
Q1 | $99K | Sell |
1,197
-1,773
| -60% | -$173K | ﹤0.01% | 4783 |
|
|
2019
Q4 | $329K | Sell |
2,970
-8,936
| -75% | -$919K | ﹤0.01% | 4273 |
|
|
2019
Q3 | $1.18M | Buy |
11,906
+4,638
| +64% | +$461K | ﹤0.01% | 3216 |
|
|
2019
Q2 | $722K | Buy |
7,268
+4,312
| +146% | +$412K | ﹤0.01% | 3586 |
|
|
2019
Q1 | $325K | Buy |
2,956
+2,615
| +767% | +$273K | ﹤0.01% | 4044 |
|
|
2018
Q4 | $32K | Sell |
341
-20,159
| -98% | -$2.04M | ﹤0.01% | 5358 |
|
|
2018
Q3 | $2.26M | Buy |
20,500
+18,379
| +867% | +$1.91M | ﹤0.01% | 2760 |
|
|
2018
Q2 | $198K | Sell |
2,121
-164,909
| -99% | -$14.2M | ﹤0.01% | 4413 |
|
|
2018
Q1 | $13.9M | Sell |
167,030
-24,817
| -13% | -$2.21M | 0.01% | 1326 |
|
|
2017
Q4 | $17.5M | Buy |
191,847
+43,717
| +30% | +$3.64M | 0.01% | 1221 |
|
|
2017
Q3 | $11.3M | Buy |
148,130
+141,504
| +2,136% | +$10.7M | 0.01% | 1450 |
|
|
2017
Q2 | $496K | Buy |
6,626
+5,845
| +748% | +$405K | ﹤0.01% | 3666 |
|
|
2017
Q1 | $51K | Sell |
781
-617
| -44% | -$36.3K | ﹤0.01% | 5145 |
|
|
2016
Q4 | $77K | Sell |
1,398
-21,963
| -94% | -$1.21M | ﹤0.01% | 5019 |
|
|
2016
Q3 | $1.32M | Buy |
23,361
+18,967
| +432% | +$930K | ﹤0.01% | 2873 |
|
|
2016
Q2 | $183K | Sell |
4,394
-680
| -13% | -$31.3K | ﹤0.01% | 4458 |
|
|
2016
Q1 | $217K | Buy |
5,074
+197
| +4% | +$8.32K | ﹤0.01% | 4311 |
|
|
2015
Q4 | $221K | Buy |
4,877
+4,029
| +475% | +$169K | ﹤0.01% | 4448 |
|
|
2015
Q3 | $33K | Sell |
848
-5
| -0.6% | -$200 | ﹤0.01% | 5348 |
|
|
2015
Q2 | $31K | Buy |
853
+596
| +232% | +$18.9K | ﹤0.01% | 5476 |
|
|
2015
Q1 | $7K | Buy |
+257
| New | +$7.17K | ﹤0.01% | 5678 |
|
Other funds holding PRAH
Royal Bank of Canada's PRAH Position: Q3 2021 in Review
Royal Bank of Canada sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 18,255 shares — an estimated $3.02M sold.
Royal Bank of Canada first reported a position in PRAH in Q1 2015 and held it in 26 quarters. The position peaked at $17.5M in Q4 2017. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Royal Bank of Canada reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Royal Bank of Canada sold 18,255 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $3.02M.
- Royal Bank of Canada first reported a position in PRA Health Sciences, Inc. in Q1 2015 and held it in 26 quarters.
- Royal Bank of Canada's PRA Health Sciences, Inc. position peaked at $17.5M in Q4 2017.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Royal Bank of Canada's 13F filing for Q3 2021, filed 15 Nov 2021.